Revolutionizing Neuromonitoring: WISE SpA Secures $25 Million in Funding for Supersonic Technology

WISE SpA, a pioneering medical device company at the forefront of neuromonitoring and neuromodulation, has successfully raised €25,000,000 in its latest funding round. The investment will significantly enhance WISE's capabilities to further develop its groundbreaking Supersonic Technology, which is revolutionizing how implantable leads are designed for neuromonitoring. Known for its soft, thin, and highly ergonomic electrodes, WISE is committed to delivering solutions that ensure minimal invasiveness and maximum adaptability to nervous tissue—a critical factor in surgical procedures. The first commercial offering from WISE, the CE-marked WISE Cortical Strip (WCS®), has already made waves in the medical community as a reliable tool for IntraOperative Neurophysiological Monitoring (IONM) during brain tumor and epilepsy surgeries. This single-use device allows for the continuous recording of the brain’s spontaneous electrical activity and facilitates brain stimulation, crucial for eliciting motor evoked potentials. With this substantial funding, WISE plans to scale production capabilities, advance its research on additional applications of its Supersonic Technology, and expand its market reach, potentially making significant impacts on surgical outcomes and patient safety. As the demand for innovative medical solutions continues to grow, WISE is poised to lead the way in developing advanced neuromonitoring devices that prioritize both efficacy and patient comfort.